Jazz Pharmaceuticals PLC banner

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 180.45 USD -0.51% Market Closed
Market Cap: $11.1B

Balance Sheet

Balance Sheet Decomposition
Jazz Pharmaceuticals PLC

Balance Sheet
Jazz Pharmaceuticals PLC

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
21
79
103
25
16
45
82
387
637
684
989
366
386
216
333
517
511
851
1 506
2 413
1 392
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
216
333
517
511
334
438
949
683
Cash Equivalents
21
79
103
25
16
45
82
387
637
684
989
366
386
0
0
0
0
517
1 069
1 464
709
Short-Term Investments
0
0
0
1
0
0
76
0
0
0
0
60
215
609
744
1 616
81
30
120
580
1 050
Total Receivables
4
5
5
7
12
22
34
75
125
186
210
234
224
264
356
396
563
743
855
717
831
Accounts Receivables
4
5
5
7
12
22
34
75
125
186
210
234
224
264
356
396
563
651
706
717
831
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92
149
0
0
Inventory
3
3
2
4
3
5
4
27
29
30
19
34
43
53
79
95
1 073
714
597
480
417
Other Current Assets
4
4
5
7
6
3
3
62
74
116
40
54
100
93
118
214
383
268
357
439
476
Total Current Assets
31
92
116
44
37
74
199
552
865
1 016
1 258
748
968
1 234
1 630
2 840
2 611
2 606
3 435
4 629
4 166
PP&E Net
2
2
4
3
1
1
2
7
14
58
86
107
170
200
271
257
343
301
235
227
259
PP&E Gross
2
2
4
3
1
1
2
7
14
58
86
107
170
200
271
257
343
301
235
227
259
Accumulated Depreciation
1
1
3
4
5
6
7
8
11
15
24
32
41
50
55
68
85
108
133
162
179
Intangible Assets
79
69
36
33
30
22
15
870
812
1 437
1 186
3 012
2 979
2 731
2 441
2 195
7 152
5 794
5 418
4 756
4 430
Goodwill
39
38
38
38
38
38
38
443
450
703
657
894
948
928
920
958
1 828
1 693
1 753
1 716
1 829
Other Long-Term Assets
14
14
13
0
1
0
0
95
97
125
147
39
59
110
277
286
364
441
552
684
976
Other Assets
39
38
38
38
38
38
38
443
450
703
657
894
948
928
920
958
1 828
1 693
1 753
1 716
1 829
Total Assets
165
N/A
215
+30%
208
-3%
117
-44%
107
-9%
136
+27%
254
+87%
1 966
+674%
2 238
+14%
3 339
+49%
3 333
0%
4 800
+44%
5 124
+7%
5 203
+2%
5 539
+6%
6 536
+18%
12 299
+88%
10 835
-12%
11 393
+5%
12 012
+5%
11 659
-3%
Liabilities
Accounts Payable
5
5
3
6
2
3
5
16
21
25
22
22
24
41
48
27
100
91
103
78
122
Accrued Liabilities
11
13
29
16
12
13
20
105
120
164
164
193
199
263
267
349
647
803
793
900
1 030
Short-Term Debt
0
2
3
4
9
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
119
24
16
0
30
6
9
38
36
41
33
33
246
31
31
605
31
1 030
Other Current Liabilities
7
10
1
29
12
20
28
41
58
18
3
6
30
8
17
31
30
8
36
29
61
Total Current Liabilities
23
31
37
173
59
60
53
192
204
217
227
257
294
345
364
654
809
933
1 537
1 039
2 243
Long-Term Debt
89
74
75
0
91
25
0
427
544
1 333
1 151
1 994
1 540
1 563
1 574
1 849
6 025
5 699
5 113
6 082
4 332
Deferred Income Tax
0
0
0
0
0
0
0
178
168
375
283
557
383
309
224
130
1 301
944
848
677
594
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
14
27
24
30
21
8
48
26
43
73
115
193
228
265
243
198
173
159
121
172
Total Liabilities
113
N/A
119
+5%
139
+17%
198
+42%
180
-9%
105
-42%
61
-42%
845
+1 285%
943
+12%
1 968
+109%
1 734
-12%
2 923
+69%
2 411
-18%
2 446
+1%
2 428
-1%
2 876
+18%
8 333
+190%
7 750
-7%
7 656
-1%
7 919
+3%
7 341
-7%
Equity
Common Stock
164
264
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
118
178
316
501
508
475
350
61
19
35
303
529
918
842
1 068
1 160
831
734
879
1 128
647
Additional Paid In Capital
0
1
371
408
435
505
543
1 151
1 220
1 458
1 563
1 665
1 935
2 114
2 266
2 634
3 535
3 477
3 700
3 914
4 240
Other Equity
6
8
13
12
0
0
0
31
56
122
267
317
141
198
223
134
400
1 126
842
948
569
Total Equity
52
N/A
96
+85%
68
-29%
80
N/A
73
+9%
31
N/A
193
+523%
1 121
+481%
1 296
+16%
1 371
+6%
1 599
+17%
1 877
+17%
2 713
+45%
2 757
+2%
3 111
+13%
3 660
+18%
3 965
+8%
3 086
-22%
3 737
+21%
4 094
+10%
4 319
+5%
Total Liabilities & Equity
165
N/A
215
+30%
208
-3%
117
-44%
107
-9%
136
+27%
254
+87%
1 966
+674%
2 238
+14%
3 339
+49%
3 333
0%
4 800
+44%
5 124
+7%
5 203
+2%
5 539
+6%
6 536
+18%
12 299
+88%
10 835
-12%
11 393
+5%
12 012
+5%
11 659
-3%
Shares Outstanding
Common Shares Outstanding
25
25
25
29
31
40
42
58
58
61
61
60
60
58
56
56
62
63
62
61
61
Preferred Shares Outstanding
11
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett